Suppr超能文献

利巴韦林对犬瘟热病毒的体外疗效

In vitro efficacy of ribavirin against canine distemper virus.

作者信息

Elia Gabriella, Belloli Chiara, Cirone Francesco, Lucente Maria Stella, Caruso Marta, Martella Vito, Decaro Nicola, Buonavoglia Canio, Ormas Paolo

机构信息

Department of Animal Health and Well-being, Faculty of Veterinary Medicine of Bari, 70010 Valenzano, Bari, Italy.

出版信息

Antiviral Res. 2008 Feb;77(2):108-13. doi: 10.1016/j.antiviral.2007.09.004. Epub 2007 Oct 8.

Abstract

Despite vaccination, canine distemper virus (CDV) remains one of the important pathogen of dogs with worldwide distribution. Ribavirin (RIB) inhibits replication of measles virus (MV), a morbillivirus closely related to CDV, both in vitro and in vivo. In this report the antiviral activity of RIB against CDV in cell cultures was assessed. Quantitative real-time RT-PCR was used to measure viral RNA in VERO cells infected by CDV and to evaluate the inhibitory effects of RIB. RIB caused a dose- and time-dependent decrease in accumulation of CDV RNA when added after virus adsorption. RIB was highly effective in preventing CDV replication at low concentrations with 50% virus-inhibitory concentrations ranging from 0.02 to 0.05 mM. Such low values were comparable to values displayed by highly susceptible strains of MV. In addition, CDV was passaged sequentially in VERO cell monolayers in the presence of RIB to trigger viral extinction. The virus was no longer detected after three passages, suggesting that error catastrophe is one of the modes of action of RIB against CDV. These findings suggest RIB as a promising tool for the therapy of CD in dogs.

摘要

尽管进行了疫苗接种,但犬瘟热病毒(CDV)仍然是在全球范围内分布的犬类重要病原体之一。利巴韦林(RIB)在体外和体内均能抑制麻疹病毒(MV)的复制,麻疹病毒是一种与CDV密切相关的副黏病毒。在本报告中,评估了RIB在细胞培养物中对CDV的抗病毒活性。采用定量实时RT-PCR来测量感染CDV的VERO细胞中的病毒RNA,并评估RIB的抑制作用。在病毒吸附后添加RIB时,RIB导致CDV RNA的积累呈剂量和时间依赖性下降。RIB在低浓度下对预防CDV复制非常有效,其50%病毒抑制浓度范围为0.02至0.05 mM。如此低的值与高度敏感的MV毒株所显示的值相当。此外,在存在RIB的情况下,CDV在VERO细胞单层中连续传代以引发病毒灭绝。传代三次后不再检测到病毒,这表明错误灾难是RIB对抗CDV的作用模式之一。这些发现表明RIB是治疗犬类CD的一种有前景的工具。

相似文献

1
In vitro efficacy of ribavirin against canine distemper virus.
Antiviral Res. 2008 Feb;77(2):108-13. doi: 10.1016/j.antiviral.2007.09.004. Epub 2007 Oct 8.
2
Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
Res Vet Sci. 2010 Apr;88(2):339-44. doi: 10.1016/j.rvsc.2009.08.010. Epub 2009 Sep 24.
3
Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro.
J Virol Methods. 2017 Oct;248:207-211. doi: 10.1016/j.jviromet.2017.07.012. Epub 2017 Jul 29.
4
Inhibition of viral RNA synthesis in canine distemper virus infection by proanthocyanidin A2.
Antiviral Res. 2011 Dec;92(3):447-52. doi: 10.1016/j.antiviral.2011.10.004. Epub 2011 Oct 13.
5
Error-prone replication of West Nile virus caused by ribavirin.
Antiviral Res. 2005 Jul;67(1):38-45. doi: 10.1016/j.antiviral.2005.04.002.
7
In vitro antiviral efficacy of caffeic acid against canine distemper virus.
Microb Pathog. 2017 Sep;110:240-244. doi: 10.1016/j.micpath.2017.07.006. Epub 2017 Jul 4.

引用本文的文献

3
Bedd. root-derived flavonoids as prominent antiviral agents against Newcastle disease virus.
RSC Adv. 2020 Sep 10;10(55):33534-33543. doi: 10.1039/d0ra01820a. eCollection 2020 Sep 7.
5
An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
Front Pharmacol. 2021 Mar 8;12:632677. doi: 10.3389/fphar.2021.632677. eCollection 2021.
6
Recovery of NanoLuc Luciferase-Tagged Canine Distemper Virus for Facilitating Rapid Screening of Antivirals .
Front Vet Sci. 2020 Dec 10;7:600796. doi: 10.3389/fvets.2020.600796. eCollection 2020.
7
Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
Pharmaceutics. 2018 Mar 26;10(2):39. doi: 10.3390/pharmaceutics10020039.
8
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.
Drug Deliv. 2018 Nov;25(1):376-387. doi: 10.1080/10717544.2018.1428242.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验